Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Shaman Pharmaceuticals (OTC BB:SHPHE.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: News | Profile
Recent Events
Aug 31Price hit new 52-week low ($0.008)
Location
213 East Grand Avenue
South San Francisco, CA 94080
Phone: (650) 952-7070
Fax: (650) 873-8367
Email: kpyne@shaman.com
Employees (last reported count): 14
Financial Links
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 55%
·Institutional: 0% (1% of float)
(7 institutions)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Shaman Pharmaceuticals, Inc., through the main operating division of ShamanBotancials.com, is focused on the discovery, development and marketing of novel, proprietary botanical dietary supplements derived from tropical plant sources. The Company's commercialization plans include the use of community-building initiatives on the Internet and other distribution channels, and is based on marketing its exclusive access to its proprietary branded products. The Company also has available for out-licensing a pipeline of botanical product candidates, as well as novel pharmaceutical product candidates for major human diseases developed by isolating active compounds from tropical plants with a history of medicinal use.
More from Market Guide: Expanded Business Description

Financial Summary
Shaman Pharmaceuticals is engaged in the discovery, development, and marketing of novel proprietary botanical dietary supplements derived from tropical plants sources with a history of medicinal uses. For the three months ended 3/31/01, revenues totaled $232 thousand, up from $53 thousand. Net loss applicable to Common fell 97% to $250 thousand. Results reflect license agreements revenues, and the absence of $2.9 million in interest expense and $2.5 million in preferred stock dividends.
More from Market Guide: Significant Developments

Officers
FY2000 Pay

Lisa Conte, 42
Pres, CEO, Chief Financial Officer, Director
$232K
Stephen King, Ph.D., 43
COO, Sr. VP of Ethnobotany and Conservation
180K
Gerald Reaven, M.D., 72
Sr. VP, Clinical Research
--  
Thomas White, 42
Sr. VP of Commercial Strategy and Chief Sales and Marketing Officer
181K
Thomas Carlson, M.D., 43
VP of Medical Ethnobotany
138K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:SHPHE.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 31-Aug-2001
$0.008
Recent Price$0.009
52-Week High
on 1-Sep-2000
$0.125
Beta-1.22 
Daily Volume (3-month avg)120.6K
Daily Volume (10-day avg)154.0K
Stock Performance
52-Week Change-91.7%
52-Week Change
relative to S&P500
-88.9%
Share-Related Items
Market Capitalization$931.0K
Shares Outstanding103.5M
Float46.6M
Dividends & Splits
Annual Dividendnone 
Last Split: 1 for 49 on 1-Feb-2000
Per-Share Data
Book Value (mrq)-$0.10 
Earnings (ttm)-$0.22 
Earnings (mrq)-$0.00 
Sales (ttm)$0.01 
Cash (mrq)$0.00 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/Sales (ttm)1.66 
Income Statements
Sales (ttm)$475.0K
EBITDA (ttm)-$11.9M
Income available to common (ttm)-$16.7M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter31-Mar-2001
Management Effectiveness
Return on Assets (ttm)-388.88%
Return on EquityN/A 
Financial Strength
Current Ratio (mrq)0.11 
Debt/EquityN/A 
Total Cash (mrq)$92.0K
Short Interest
As of 8-Feb-1999
Shares Short0 
Shares Short
(Prior Month)
58.0K
Daily Volume42.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.